The Irish Medicines Board - www.imb.ie

• Legislation

• Links

• Events

• News

• Consultation

• Contact Us

• Recruitment

• Privacy

• Contacts

• Disclaimer

• FAQs

• About Us
  • Organisational Structure
    • Board & Committees
    • Organisational Structure
    • Personnel
  • Freedom of Information
  • Working with the IMB
  • Customer Service
  • Quality Management
  • Location

• Copyright

• Safety & Quality
  • Advisory, Warning & Recall Notices
    • Human Medicines
      • Important Safety Warning: Relenza inhalation powder must not be nebulised or administered by mechanical ventilation.
    • Medical Devices
    • Blood, Tissues & Cells
    • Veterinary Medicines
  • How the IMB monitors product safety
    • Human Medicines
      • Drug Safety
      • Market Compliance
      • Defects in Medicines
    • Medical Devices
    • Tissues & Cells
    • Blood
    • Veterinary Medicines
  • Reporting Suspected Product Problems
    • Safety Related Problems
    • Quality Related Problems
    • Product Recalls
  • Online Forms
    • Human Medicine -Adverse Reaction
    • Clinical Trial-Serious Adverse Event
    • Tissues&Cells-Adverse Reaction/Event
    • Quality Defect
    • Medical Device Incident User Report Form
    • Veterinary Medicine - Adverse Reaction

• Medicines
  • Pandemic (H1N1) 2009
    • Anti-viral Medication
    • ADR Reporting
    • Counterfeit Medication
  • Human Medicines
    • Licensing
      • New Product
      • Variation
      • Renewal
      • Transfer
      • Withdrawal
      • Parallel Importation
      • Homeopathics
      • Periodic Safety Updates
      • Fees
      • On-Line Applications
    • Herbal Medicines
    • Homeopathic Medicines
    • Vaccines
    • Human Medicines Listing
    • Drug-Device Combination Products
  • Clinical Trials
    • Good Clinical Practice (GCP)
    • Licensing
    • Serious Adverse Event form
  • Veterinary Medicines
    • Licensing
      • New Product
      • Variation
      • Renewal
      • Transfer
      • Withdrawal
      • Parallel Importation
      • Fees
      • Herbals
      • Homeopathics
    • Classification Enquiries
    • Availability
    • Veterinary Medicines Listing
  • Manufacturing
    • Licencing
      • New Applications
      • Renewals
      • Variation Application
    • Authorised Manufacturers List
  • Laboratory
  • Wholesale Distribution
    • Licensing
      • New Applications
      • Variation Applications
      • Renewal Applications
    • Authorised Wholesalers List
  • Export Certification
  • Controlled Drugs and Precursor Chemicals
  • Classification of Medicines

• Medical Devices
  • Pre-Market Activities
    • Clinical Investigations
    • Registration
    • Classification
    • Notified Body Management
    • Drug-Device Combination Products
  • Post-Market Activities
    • Vigilance
    • Certificates of Free Sale
    • Compliance
  • Auditing & Surveillance
  • On-Line Services
  • Information Leaflets
  • Safety Notices
  • European Pilot for Electronic Reporting of Incidents
  • SCHENIR Report: The safety of dental amalgam and alternative dental restoration materials for patien

• Blood, Tissues & Cells
  • Blood
    • Hospital Blood Bank Annual Report (HBBAR)
  • Tissues & Cells
  • Blood & Tissue Establishments

• Cosmetics
  • test page

• Publications